InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Karpf David B, Directeur Médical. Insider active across 2 companies, notably LUMOS PHARMA, INC.. Cumulatively, 3 reports have been logged. Activity tracked since 1 February 2022. The latest transaction was filed on 1 February 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
David B. Karpf is the Chief Medical Officer at Lumos Pharma, Inc. He oversees the company's medical and clinical initiatives, ensuring innovation and efficacy in treatments. David B. Karpf plays a key role in the medical direction of the company, contributing to its success in the biotechnology field.